- About
- PsychU For You
- Topics
- Events
- Content
Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
About This Event
Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
This is a private Live Event for the members of the Louisiana Association of Nurse Practitioners.
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.
Milano
Amaka Onyereri, PharmD, BCPS (OPDC)
Medical Science Liaison
MoreAmaka Onyereri received her bachelor’s degree in general science and Doctor of Pharmacy degree from Oregon State University/Oregon Health Sciences University. Her passion for patient care led her to practice clinically as a community pharmacist where she served patients for close to 20 years in different capacities as a staff pharmacist, pharmacy manager and pharmacy clinical services manager. As a Pharmacy Clinical Services Manager, Amaka spearheaded various clinical and patient care initiatives such as immunizations, medication therapy management, point of care testing, and most recently a long-acting injectables pilot for antipsychotics.Speaker Amaka Onyereri, PharmD, BCPS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.
- PsychU For You
